Benzamide derivatives
US5238962A · kind A · utility
5Cited by
14References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 9, 1992 |
| Grant date | Aug 24, 1993 |
| Priority date | — |
| Expiry date | Jun 9, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D317/68
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Benzamides of the formula ##STR1## wherein R.sup.1 and R.sup.2 each independently is hydrogen, halogen, lower alkyl, lower alkoxy, cyano, trifluoromethyl, sulfamoyl, mono(lower alkyl)sulfamoyl or di(lower alkyl)sulfamoyl or R.sup.1 and R.sup.2 on adjacent carbon atoms together are a methylenedioxy group, with the proviso that R.sup.2 is different from hydrogen when R.sup.1 are bromine in the 3-position, and their pharmaceutically acceptable acid addition salts have monoamine oxidase inhibiting properties with low toxicity and can accordingly be used for the treatment of depressive states and Parkinsonism.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.